Docoh
Loading...

ACUR Acura Pharmaceuticals

Acura Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of abuse deterrent, orally administered pharmaceutical products. Its technology platforms include AVERSION, IMPEDE, and LIMITX. The company was founded on April 10, 1935 and is headquartered in Palatine, IL.

Company profile

Ticker
ACUR
Exchange
Website
CEO
Robert Jones
Employees
Incorporated
Location
Fiscal year end
Former names
HALSEY DRUG CO INC/NEW
SEC CIK
IRS number
110853640

ACUR stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

17 May 21
1 Aug 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 361K 361K 361K 361K 361K 361K
Cash burn (monthly) 17.33K 70.75K 86.33K 63.25K 104.33K 114.92K
Cash used (since last report) 70.37K 287.24K 350.51K 256.79K 423.59K 466.55K
Cash remaining 290.63K 73.76K 10.49K 104.21K -62.59K -105.55K
Runway (months of cash) 16.8 1.0 0.1 1.6 -0.6 -0.9

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
9 Jun 21 Schutte John Common Stock Conversion Aquire C Yes No 0.16 42,984,375 6.88M 42,984,375
9 Jun 21 Schutte John Convertible Promissory Note Common Stock Conversion Dispose C Yes No 0.16 - 6.88M 0
9 Jun 21 Abuse Deterrent Pharma Common Stock Conversion Aquire C No No 0.16 42,984,375 6.88M 42,984,375
9 Jun 21 Abuse Deterrent Pharma Convertible Promissory Note Common Stock Conversion Dispose C No No 0.16 6,877,500 1.1M 0
25 May 21 William G Skelly RSU Common Stock Grant Aquire A No No 0 66,666 0 66,666
25 May 21 Immanuel Thangaraj RSU Common Stock Grant Aquire A No No 0 66,666 0 66,666
25 May 21 George K Ross RSU Common Stock Grant Aquire A No No 0 66,666 0 66,666

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

0.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 2 2
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 1.03K 1.03K
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Lenox Wealth Advisors 780 $0 0.0%
Captrust Financial Advisors 245 $0 0.0%
Largest transactions
Shares Bought/sold Change
Captrust Financial Advisors 245 0 0.0%
Lenox Wealth Advisors 780 0 0.0%

Financial report summary

?
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: adherence, attendant, awaiting, cardiovascular, civilian, cocaine, compliance, decided, deemed, deemphasized, delinquent, diagnosed, died, enhance, exacerbating, exceeded, fed, found, good, half, hard, heroin, Inter, intraperiod, killed, lethal, lethality, licit, nonrecurring, notified, older, OUD, owner, past, pertaining, pharmacologic, pharmacology, portfolio, quality, ready, regression, remitting, renegotiate, resolution, run, SBA, sedative, shelf, shifted, simplify, Simplifying, sought, St, stimulant, substituting, synergistic, timepoint, toxicity, toxicologic, unchanged, University, unsafe, Washington
Removed: absorption, abused, abuser, abusing, abusive, accentuate, accidently, accredited, achieve, acidity, addictive, adequate, administering, Advil, agency, agent, aggregated, aggregating, alcohol, alternative, animal, AP, assignable, attractive, August, Bayer, begin, bloodstream, borrowing, bridge, broad, capacity, capsule, care, cease, centralized, certainty, chance, Chattem, chemically, chewed, cohort, collaborative, collateral, comparing, complementary, comply, complying, comprise, conducting, confirmed, considerable, correction, DEA, defeat, defending, delivered, demand, desired, deter, deterrence, differentiate, differentiated, Dilaudid, dilutive, discount, Disease, disrupt, distinguished, diversion, domestic, downturn, economically, element, emptying, enable, enforcing, enrolled, enrollment, ETA, euphoria, evolve, exempt, expended, explore, extinguishment, extractability, fail, faster, fastest, fear, feature, fluid, forensic, fourth, functionality, grow, growing, harm, healthcare, heighten, heightened, history, hospital, Ibuprofen, illegal, imputed, inappropriately, incorporate, incorporating, induce, ingest, ingestion, initiation, injected, insufflated, intent, intention, interrupt, interruption, introduce, link, Lorcet, Lortab, manipulated, manipulating, manner, mature, Measurement, mechanism, merchandising, misused, misusing, modified, monitor, morphine, movement, MTA, naloxone, naltrexone, nation, negative, neutralize, noting, objective, offer, ongoing, operate, optimization, outcome, Oxford, OxyContin, particle, patient, perception, pH, physical, physically, pledged, predominately, premium, prescribe, prescribing, prevent, primary, prime, prioritization, problem, produced, promotable, promulgated, proportionality, prosecuting, protocol, publicity, quantified, rapidly, recent, recession, recruit, referred, reformulate, Regulation, relinquish, reluctant, represent, restrictive, retain, retention, satisfactory, scientific, sell, serviced, show, simply, simultaneously, site, sixteen, split, stability, Stocking, strategic, strategy, subgroup, Substance, suffer, surged, sustain, swallowing, syringe, syringeability, tampering, Tmax, topline, unamortized, unanticipated, understood, undisclosed, unsecured, upcoming, user, variety, vast, vein, Vicodin, vitro, washout, week, widespread, worsening

Patents

APP
Utility
Methods and Compositions for Self-regulated Release of Active Pharmaceutical Ingredients
22 Apr 21
An abuse deterrent pharmaceutical composition including a drug susceptible to abuse, a first acid soluble ingredient, a first buffering ingredient, and a delayed release buffering component.
APP
Utility
Abuse Deterrent Compositions and Methods of Making Same
18 Mar 21
This invention relates a therapeutic pharmaceutical composition comprising: a mixture including an opioid; polyethylene oxide in an amount of about 3 to about 40 wt % of the composition; a disintegrant; and a surfactant; wherein the disintegrant is present in an amount sufficient to cause the pharmaceutical composition to exhibit an immediate release profile.
APP
Utility
Methods and Compositions for Self-regulated Release of Active Pharmaceutical Ingredient
2 Dec 20
An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.
GRANT
Utility
Methods and compositions for self-regulated release of active pharmaceutical ingredient
22 Jun 20
An abuse deterrent pharmaceutical composition including a pharmaceutically active ingredient; an acid soluble ingredient; and a buffering ingredient; wherein the acid soluble ingredient and the buffering ingredient retard release of the active pharmaceutical ingredient when the composition is ingested in excess of an intended dosage.
APP
Utility
Methods and Compositions for Interfering with Extraction or Conversion of a Drug Susceptible to Abuse
17 Jun 20
Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse.